Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Efficacy and Safety of Ixekizumab in Patients with Active Psoriatic Arthritis and Previous Inadequate Response to TNF Inhibitors: 52-Week Results from a Phase 3 Study Genovese, M. C., Combe, B., Kremer, J., Adams, D., Lee, C., Kerr, L., Nash, P. WILEY. 2017
View details for Web of Science ID 000411824106473